Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Johnson and Johnson
McKinsey
Merck
Harvard Business School

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

Details for Biologics License Application: 103786

See Plans and Pricing

« Back to Dashboard

Summary for BLA: 103786
Tradename:RETAVASE
Applicant:Ekr Therap
Ingredient:reteplase
Patents:56
Approval Date:May 06, 1998
Suppliers: see list1

US Patents for BLA: 103786

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Ekr Therap RETAVASE reteplase VIAL 103786 001 1998-05-06   Request a Trial TECHNISCHE UNIVERSITAT MUNCHEN (Munich, DE) XL-PROTEIN GMBH (Freising, DE) 2030-05-21 RX search
Ekr Therap RETAVASE reteplase VIAL 103786 001 1998-05-06   Request a Trial CureVac AG (Tubingen, DE) 2032-02-15 RX search
Ekr Therap RETAVASE reteplase VIAL 103786 001 1998-05-06   Request a Trial ALEXION PHARMACEUTICALS, INC. (New Haven, CT) 2024-12-29 RX search
Ekr Therap RETAVASE reteplase VIAL 103786 001 1998-05-06   Request a Trial MURRAY AND POOLE ENTERPRISES LTD (Gibraltar, GB) 2032-11-02 RX search
Ekr Therap RETAVASE reteplase VIAL 103786 001 1998-05-06   Request a Trial 2032-04-02 RX search
Ekr Therap RETAVASE reteplase VIAL 103786 001 1998-05-06   Request a Trial INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) COLLEGE DE FRANCE (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Creteil, FR) UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (Creteil, FR) ASSI 2035-01-06 RX search
Ekr Therap RETAVASE reteplase VIAL 103786 001 1998-05-06   Request a Trial CSL Limited (Parkville, Victoria, AU) B-Creative Sweden AB (Balsta, SE) 2034-11-17 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Colorcon
McKesson
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.